Posted on 7/18/19
AzurRx BioPharma Proposes Public Offering of Common Stock
BROOKLYN, N.Y., July 17, 2019 (GLOBE NEWSWIRE) -- AzurRx BioPharma (NASDAQ: AZRX), announced today that it intends to offer and sell shares of its common stock . . .
Posted on 7/18/19
Amarin Announces $400M Public Offering of American Depositary Shares
BEDMINSTER, N.J. and DUBLIN, Ireland, July 17, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced that it has commenced an underwritten public offering . . .
Posted on 7/18/19
Delcath Systems Closes $20 Million Private Placement
NEW YORK, July 17, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCPK: DCTH) has closed on its previously announced private placement with gross proceeds of $20 . . .
Posted on 7/18/19
Bayer, Bristol-Myers Squibb and Ono Pharmaceutical Enter Into a Clinical Collaboration Agreement
WHIPPANY, N.J. & PRINCETON, N.J. & OSAKA, Japan--(BUSINESS WIRE)--Bayer, Bristol-Myers Squibb Company (NYSE: BMY) and Ono Pharmaceutical Co., Ltd. announced today the three companies have entered into . . .
Posted on 7/18/19
Quest Diagnostics Welcomes New Members to the Global Diagnostics Network
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the expansion of the Global Diagnostics Network (GDN), a strategic working group . . .
Posted on 7/18/19
HLTH and Evercore ISI Partner
HLTH, the largest and most important conference for health innovation, and Evercore (NYSE: EVR) announced today a new collaboration to host a series of panels on . . .
Posted on 7/18/19
Regeneron Announces the 2019 Winners of the Regeneron Prize for Creative Innovation
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced the winners of the seventh annual Regeneron Prize for Creative Innovation. The country's leading research universities were asked to nominate . . .
Posted on 7/18/19
Abeona Therapeutics: A True Test Looms As Cash Dwindles
SummaryValuation of Abeona Therapeutics has suffered in the last few months by means of catalyst setbacks and dwindling cash runway.A technical glance at Abeona's price chart . . .
Posted on 7/18/19
Bioasis Announces Stock Option Grants
GUILFORD, Conn.--(BUSINESS WIRE)--Bioasis Technologies Inc. (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology for the delivery of therapeutics across the . . .
Posted on 7/17/19
BeyondSpring Prices Public Offering of Ordinary Shares
NEW YORK, July 17, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (Nasdaq: BYSI), a global clinical stage biopharmaceutical company focused on the development and commercialization of innovative immuno-oncology . . .
Posted on 7/17/19
Quest Diagnostics Named one of the "Best Places to Work for Disability Inclusion"
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has been named to the 2019 Disability Equality Index (DEI) "Best . . .
Posted on 7/17/19
Field Neuro-enhancement Announces Collaboration with Blum Center for Health
Field, the pioneer in personalized brain optimization, announces it has successfully launched a collaboration with the renowned Blum Center for Health led by the esteemed doctor . . .
Posted on 7/17/19
Cigna and Express Scripts Named Best Places to Work for Disability Inclusion
BLOOMFIELD, Conn.--(BUSINESS WIRE)--Global health service company Cigna and its Express Scripts business were both named as a Best Place to Work for Disability Inclusion after earning . . .
Posted on 7/17/19
Catholic Health Services Partners with Quest Diagnostics
Catholic Health Services (CHS), an integrated health care delivery system with a 24% market share on Long Island, is teaming up with Quest Diagnostics (NYSE: DGX), . . .
Posted on 7/17/19
Cara Therapeutics: Wait For A Better Entry Opportunity
Summary Cara's stock has risen over 100% YTD and 30% over the Last Month. Cara has a strong pipeline, making it an attractive long term investment . . .
Posted on 7/17/19
Johnson & Johnson (JNJ) Q2 2019 Results - Earnings Call Transcript
Johnson & Johnson (NYSE:JNJ) Q2 2019 Earnings Conference Call July 16, 2019 8:30 AM ETCompany ParticipantsChris DelOrefice - Vice President of Investor RelationsJoe Wolk - Executive . . .
Posted on 7/17/19
Tonix Pharmaceuticals Prices Public Offering of Common Stock
NEW YORK, July 16, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the pricing . . .
Posted on 7/17/19
Eyenovia Closes Public Offering
NEW YORK, July 15, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its . . .
Posted on 7/17/19
BeyondSpring Proposes Public Offering of Ordinary Shares
NEW YORK, July 16, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc.(Nasdaq: BYSI), a global clinical stage biopharmaceutical company focused on the development and commercialization of innovative immuno-oncology . . .
Posted on 7/16/19
OncoSec Issues Letter to Shareholders
OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing late-stage intratumoral cancer immunotherapies, today published a Letter to Shareholders from President and Chief Executive Officer, Daniel J. . . .
Posted on 7/16/19
Blink Health Hires Former Compass & Microsoft Executive Eytan Seidman as Head of Product
NEW YORK--(BUSINESS WIRE)--Blink Health, the app that lets people get their prescription medication at much lower prices, announces that Eytan Seidman has joined the company as . . .
Posted on 7/16/19
Johnson & Johnson Reports 2019 Second-Quarter Results
Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter 2019. "We delivered solid second-quarter underlying sales growth and strong earnings growth that enables us to . . .
Posted on 7/16/19
Melinta Therapeutics Provides Corporate Update
MORRISTOWN, N.J., July 16, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to . . .
Posted on 7/16/19
2 Companies Trying to Change U.S. Healthcare
This article was first published by MyWallSt. America's healthcare system is neither healthy, caring, nor a system. -- Walter CronkiteThere are few issues in the United . . .
Posted on 7/15/19
Aquestive Therapeutics Completes $70 Million Debt Refinancing
Aquestive Therapeutics, Inc. (NASDAQ:AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products based on its proprietary PharmFilm® technology to meet patients' unmet needs . . .

